The pharmaceutical industry is continuously evolving, with increasing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, is a key copyrightple of this trend. To fulfill this demand, US-based manufacturing services are emerging. These providers offer a detailed suite of solutions, from research and de